Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present American Cryostem Corp. (OTC: CRYO).

Full DD Report for CRYO

Recent News from (OTC: CRYO)

American CryoStem Enters Into Agreement to License its Patented Adipose Tissue and Stem Cell Technologies in Thailand
EATONTOWN, N.J., April 05, 2018 (GLOBE NEWSWIRE) -- American CryoStem Corporation  (OTC:CRYO), a leading strategic application developer, marketer, global licensor of patented adipose tissue-based cellular technologies, for the Regenerative and Personalized Medicine industries, toda...
Source: GlobeNewswire
Date: April, 05 2018 06:00
Cryo Announces Notice of Allowance of Claims for Its Core Patent
EATONTOWN, NJ / ACCESSWIRE / March 27, 2018 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced receivi...
Source: ACCESSWIRE
Date: March, 27 2018 06:00
American Cryostem Corporation 2017 Year End Update
EATONTOWN, NJ / ACCESSWIRE / January 16, 2018 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today released Summary ...
Source: ACCESSWIRE
Date: January, 16 2018 06:00
American CryoStem Statement on the Receipt of a Warning Letter from FDA
EATONTOWN, NJ / ACCESSWIRE / January 8, 2018 / American CryoStem Corporation (PINK SHEETS: CRYO )) today issued a statement acknowledging that it has received a warning letter issued by the U.S. Food & Drug Administration (FDA) dated January 3, 2018 relating to its adipose derived ste...
Source: ACCESSWIRE
Date: January, 08 2018 06:00
American CryoStem Secures a Major Contract in Mainland China
EATONTOWN, NJ / ACCESSWIRE / September 25, 2017 / American CryoStem Corporation (PINK SHEETS: CRYO) today announced a major transaction in mainland China with Health Innovative Technology of Hong Kong (HIT). After more than two years as CRYO's licensee in Hong Kong, HIT has licensed the pa...
Source: ACCESSWIRE
Date: September, 25 2017 08:00
NetworkNewsBreaks - Top 10 Mid-day Percentage Gainers on September 12, 2017
Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: QTNT 29.11% – News: Posts update on performance evaluation studies for MosaiQ NVCN 9.48% – News: Provides clinical update regarding ...
Source: NetworkNewsWire
Date: September, 12 2017 13:00
COO Tony Dudzinski Highlights American CryoStem's Path to Current and Future Success
Eatontown, NJ., , Sept. 12, 2017 (GLOBE NEWSWIRE) -- Tony Dudzinski, COO of American CryoStem Corp.  ( OTCPink:CRYO ) interviews on the Uptick Network Stock Day Podcast with Host Everett Jolly. On the interview, Mr. Dudzinski elaborates the differences of the CryoStem process compar...
Source: GlobeNewswire
Date: September, 12 2017 09:30
American CryoStem Corporation Announces Financial Results for Q3 Fiscal 2017
EATONTOWN, NJ / ACCESSWIRE / August 22, 2017 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today released summary...
Source: ACCESSWIRE
Date: August, 22 2017 10:35
NetworkNewsBreaks - Top 10 Mid-day Percentage Gainers on August 14, 2017
Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: BTCS 150.24% – News: Trading higher, likely on momentum from broader bitcoin interest ZYXI 54.32% – News: Posts Q2 2017 financial re...
Source: NetworkNewsWire
Date: August, 14 2017 13:00
COO Anthony Dudzinski was Interviewed on Uptick Network on Product Importance and Company Improvements
Eatontown, NJ , Aug. 14, 2017 (GLOBE NEWSWIRE) -- COO Anthony Dudzinski was Interviewed on Uptick Network on Product Importance and Company Improvements Eatontown, NJ  Eatontown, NJ (UPTICK Newswire – August 14, 2017) - American CryoStem Corp. (OTC:Ticker CRYO) COO, Ant...
Source: GlobeNewswire
Date: August, 14 2017 09:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-190.920.920.920.921,100
2018-04-18N/A0.92N/AN/A0
2018-04-170.850.920.9390.7024,233
2018-04-160.920.93990.93990.9210,100
2018-04-150.860.93990.93990.863,740

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-04-173,30024,23313.6178Cover
2018-04-1610,00010,10099.0099Short
2018-04-131,0003,74026.7380Cover
2018-04-12500500100.0000Short
2018-04-111001,0389.6339Cover

* Cover Mode

Short Analysis provided by Squeeze Report.


About American Cryostem Corp. (OTC: CRYO)

Logo for American Cryostem Corp. (OTC: CRYO)

A pioneer in the fields of Regenerative and Personalized Medicine, American CryoStem is a developer, marketer and global licensor of patented adipose tissue based cellular technologies and related proprietary services with a focus on clinical processing, commercial bio banking and application development for adipose fat tissue and autologous adipose derived regenerative cells ADRCs . The Company maintains a strategic portfolio of intellectual property and patent applications that form its Adipose Tissue Processing Platform, which supports and promotes a growing pipeline of biologic products and processes, clinical services and international licensing opportunities. Through its ACS Laboratories division, the Company operates an FDA registered, cGMP compliant human tissue processing, cryo storage, cell culture and differentiation media development facility in Mount Laurel, New Jersey.

 

 

 

Current Management

  • John Arnone / CEO
  • Anthony Dudzinski / COO, Secretary, Treasurer
  • Ruth Goldman / Vice President, Other
  • John DiFolco / Director, Mkt.
  • John Arnone / Chairman
  • Anthony Dudzinski /

Current Share Structure

  • Market Cap: $25,490,649 - 03/20/2018
  • Authorized: 300,000,000 - 09/30/2013
  • Issue and Outstanding: 45,519,016 - 02/12/2018
  • Float: 7,820,000 - 09/30/2016

 


Recent Filings from (OTC: CRYO)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 14 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: January, 16 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: December, 29 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 12 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 21 2017
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: August, 14 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 22 2017
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: May, 15 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 21 2017
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: February, 14 2017

 

 


Daily Technical Chart for (OTC: CRYO)

Daily Technical Chart for (OTC: CRYO)


Stay tuned for daily updates and more on (OTC: CRYO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CRYO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CRYO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of CRYO and does not buy, sell, or trade any shares of CRYO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/

 

 

Release this Report to Investors

Via Email

Via Text

Important

If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us